ThursdayApr 16, 2026 12:05 pm

QualityStocksNewsBreaks – Roth Capital Partners Appoints Seth Appel Head of ATM and Equity Alternatives Banking

Roth Capital Partners announced the appointment of Seth Appel as head of ATM and equity alternatives banking, bringing more than 30 years of capital markets experience to expand the firm’s equity capital markets capabilities and support growth companies in raising capital. In connection with the appointment, Appel will also serve as co-chief investment officer of the RoHo Capital Opportunities Fund, a joint venture with Horizon Technology Finance Corporation (NASDAQ: HRZN), focused on providing debt financing solutions to small- and micro-cap public companies. To view the full press release, visit https://ibn.fm/Mxqo7 About ROTH ROTH is a relationship-driven investment bank focused on…

Continue Reading

ThursdayApr 16, 2026 11:15 am

ESGold Corp. (CSE: ESAU) (OTCQB: ESAUF) Nears Drill Program Start as Part of Multi-Pronged Gold Revenue Strategy

Disseminated on behalf of  ESGold Corp. (CSE: ESAU) (OTCQB: ESAUF)and may include paid advertising. Canadian near-term precious metal producer ESGold is advancing toward the May start of a drill program expected to further define priority targets on its 20,618-hectare Montauban Gold-Silver Project in Quebec The company is simultaneously working to construct a fully permitted mill on site and expand the scope of its exploration ESGold is employing a low CapEx strategy that includes funding from a private placement initiative and an agreement with Ocean Partners UK Ltd. that provides a credit facility and a dedicated buyer of gold and silver…

Continue Reading

ThursdayApr 16, 2026 10:30 am

Soligenix Inc. (NASDAQ: SNGX) Advances CTCL Research with Interim Analysis, Comparative Study Results

Soligenix reports clinical update centered on cutaneous T-cell lymphoma (“CTCL”), a rare form of non-Hodgkin lymphoma that primarily affects the skin. The interim update highlighted that the overall blinded aggregate response rate observed in patients who have completed treatment remains consistent with prior reporting. In addition, the company reported positive results from a study evaluating HyBryte(TM) against Valchlor(R), an existing treatment option for cutaneous T-cell lymphoma. Advancing clinical research while generating positive data is a critical combination in biotechnology, particularly when addressing diseases with limited treatment options. Soligenix (NASDAQ: SNGX) is demonstrating that momentum as it provides  both an encouraging…

Continue Reading

ThursdayApr 16, 2026 10:30 am

QualityStocksNewsBreaks – Datavault AI Inc. (NASDAQ: DVLT) Launches Quantum-Ready HPC GPU Network in New York and Philadelphia 

Datavault AI (NASDAQ: DVLT) a provider of data monetization, credentialing, digital engagement and real-world asset tokenization technologies, announced that the first sites of its quantum-ready high-performance computing GPU network are now live in New York and Philadelphia, with full commercial availability of its planned 48,000-GPU fleet expected in Q3 2026. The network, designed to operate outside the hyperscaler supply chain, will scale across 1,000 micro-edge sites in more than 100 U.S. cities and support low-latency AI inference, data tokenization and monetization through the company’s IDE(R), DataValue(R) and DataScore(R) platforms, positioning it as an alternative source of secure enterprise AI compute capacity amid ongoing GPU supply constraints. To view…

Continue Reading

ThursdayApr 16, 2026 9:48 am

QualityStocksNewsBreaks – Oncotelic Therapeutics, Inc. (OTCQB: OTLC) Reports FY 2025 Net Income of $249 Million 

Oncotelic Therapeutics (OTCQB: OTLC), a clinical-stage biopharmaceutical company focused on orphan oncology and advanced drug platforms, reported financial results for the fiscal year ended Dec. 31, 2025, with net income of approximately $249.0 million compared to a net loss of $4.8 million in FY 2024, primarily driven by a non-cash gain of approximately $365.4 million from the increased valuation of its GMP Biotechnology joint venture, partially offset by a deferred tax provision of $111.6 million. To view the full press release, visit https://ibn.fm/imTdU About Oncotelic Oncotelic (f/k/a Mateon Therapeutics, Inc.), was formed in the State of New York in 1988 as OXiGENE, Inc., was reincorporated in the State…

Continue Reading

ThursdayApr 16, 2026 9:45 am

Oncotelic Therapeutics Inc. (OTLC) Expands Beyond Biotech Through AI-Robotics Pivot, Unlocking New Value in GMP Automation

Oncotelic Therapeutics has recently entered a strategic partnership with TechForce Robotics to commercialize a PDAOAI-enhanced, GMP-compliant robotics platform The collaboration integrates AI-driven compliance systems with advanced robotics for pharmaceutical manufacturing automation This pivot underscores a broader strategy: extending Oncotelic’s AI capabilities beyond therapeutics into scalable, high-value industrial applications Oncotelic Therapeutics (OTCQB: OTLC) is signaling a significant strategic evolution, moving beyond its roots as a clinical-stage biotechnology company into the quickly expanding intersection of artificial intelligence and industrial automation. Through two closely aligned announcements, the firm has unveiled a strategic partnership with TechForce Robotics, which positions it to commercialize a next-generation,…

Continue Reading

ThursdayApr 16, 2026 9:30 am

QualityStocksNewsBreaks – Nightfood Holdings Inc. (OTCQB: NGTF) Advances Commercialization With Robotics Supply Agreement

Nightfood Holdings (OTCQB: NGTF), operating through its TechForce Robotics subsidiary, announced the execution of a strategic supply agreement with NUWA Robotics Corp. and Foxconn, marking its transition from development and pilot programs to commercial deployment of robotic platforms. The agreement establishes a framework for engineering, manufacturing and commercialization, with TechForce retaining exclusive intellectual property ownership while leveraging NUWA’s system integration expertise and Foxconn’s global manufacturing capabilities to scale production and support growing demand for its Robotics-as-a-Service model. To view the full press release, visit https://ibn.fm/Zy1Kg About TechForce Robotics TechForce Robotics, Inc., a whollyowned subsidiary of the Company, is an AI-Enhanced…

Continue Reading

ThursdayApr 16, 2026 9:00 am

American Fusion(TM) Inc. (AMFN) Expands Strategic Positioning at ARPA-E Energy Innovation Summit

American Fusion(TM) used the 2026 ARPA-E Energy Innovation Summit to advance its commercial strategy and expand relationships across the fusion ecosystem. The company is developing innovational decentralized fusion technologies through its wholly owned subsidiary, Kepler Fusion Technologies, centered on the Texatron(TM) platform, targeting data center operators and developers as an initial customer base for future power deployment. American Fusion(TM) is pursuing supply chain relationships for key fusion inputs including helium-3 and deuterium and is also evaluating a potential Frankfurt Stock Exchange listing as part of a broader capital markets strategy. American Fusion(TM) (OTC: AMFN), a developer of next-generation fusion energy…

Continue Reading

WednesdayApr 15, 2026 3:14 pm

QualityStocksNewsBreaks – SPARC AI Inc. (CSE: SPAI) (OTCQB: SPAIF) Targets Growth in Defense Sector with Strategic Appointment

Disseminated on behalf of SPARC AI Inc. (CSE: SPAI) (OTCQB: SPAIF) and may include paid advertising. SPARC AI (CSE: SPAI) (OTCQB: SPAIF) recently announced the appointment of Matt McCrann as CEO of its U.S. subsidiary, a move that signals a focused push into the world’s largest defense market. “McCrann previously served as CEO of the U.S. subsidiary of DroneShield, where he led operational expansion during a period of revenue growth and increasing federal adoption,” an article discussing this reads. “McCrann’s mandate is operational rather than symbolic. He will lead SPARC AI’s North American expansion, build out U.S. infrastructure and teams, advance field evaluations and pilot…

Continue Reading

WednesdayApr 15, 2026 2:10 pm

QualityStocksNewsBreaks – LaFleur Minerals Inc. (CSE: LFLR) (OTCQB: LFLRF) (FSE: 3WK0) Secures Up to C$30 Million Prepayment Facility and Offtake Agreement With Trafigura 

This article has been disseminated on behalf of LaFleur Minerals and may include paid advertising.  LaFleur Minerals (CSE: LFLR) (OTCQB: LFLRF) (FSE: 3WK0) announced it has selected Trafigura Canada Limited to arrange and provide a prepayment financing facility of up to C$30 million along with a gold doré offtake agreement to support development of the Swanson Gold Deposit and operations at the Beacon Gold Mill in Québec, subject to definitive agreements and due diligence. The proposed facility, which includes no commodity hedging requirements and an initial tranche of up to C$15 million, is expected to fund ramp-up toward 1,250 tonnes per day processing capacity while providing a…

Continue Reading

Market Basics

New to the micro-cap markets?Get answers to your questions about investing in Small-Cap / Micro-Cap Stocks and learn how to protect yourself.

The Basics

Newsletter Publishers

Have an up and coming newsletter and want to be included in our coverage list? Looking to get more coverage and grow subscriptions? Register for coverage.

Register

Public Companies

Are you a Small-Cap / Micro-Cap company looking for coverage? We'd love to hear from you. Fill out our quick contact form or send us a text.

Get Covered